Remove the COX-2 Inhibitors Celecoxib (Celebrex) and Valdecoxib (Bextra) from the market-CLOSED
🏛 Food and Drug Administration (FDA)FDA-2005-P-0432
Documents
2
Total comments
0
all analyzed
Comment status
Closed
Last activity
—
In this docket
Documents
Rules, notices, and supporting material — the primary rule pinned first.
📄 Primary document
- Other· Jan 25, 2005